CHLOROXYLENOL 0.30 %- chloroxylenol liquid

Chloroxylenol 0.30 % by

Drug Labeling and Warnings

Chloroxylenol 0.30 % by is a Otc medication manufactured, distributed, or labeled by Davion, Inc. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredient

Chloroxylenol 0.30 %

Purpose

Antibacterial

Use

for hand washing to decrease bacteria on the skin.

Warnings

For external use only

WHEN USING

When using this product do not get into eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if

• irritation and redness develops
• condition persists for more than 72 hours

KEEP OUT OF REACH OF CHILDREN

KEEP OUT OF REACH OF CHILDREN. If product gets in eye, flush thoroughly with water. In case of accidental ingestion, drink a glass of water to dilute.

Directions

Wet hands and forearms. Apply palmful to hands and forearms. Scrub thoroughly for 30 seconds and rinse.

Inactive ingredients

Water, Sodium Laureth Sulfate, Lauramine Oxide, Sodium Xylenesulfonate, Citric Acid, Methylisothiazolinone, Methylchloroisothiazolinone,
Fragrance, Sodium Chloride, Yellow 5, Blue 1.

NDC 42669-028-03

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

CHLOROXYLENOL 0.30 % 
chloroxylenol liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 42669-028
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
CHLOROXYLENOL (UNII: 0F32U78V2Q) (CHLOROXYLENOL - UNII:0F32U78V2Q)	CHLOROXYLENOL	3 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
SODIUM LAURETH-3 SULFATE (UNII: BPV390UAP0)
LAURAMINE OXIDE (UNII: 4F6FC4MI8W)
SODIUM XYLENESULFONATE (UNII: G4LZF950UR)
CITRIC ACID (UNII: 2968PHW8QP)
METHYLISOTHIAZOLINONE (UNII: 229D0E1QFA)
Methylchloroisothiazolinone (UNII: DEL7T5QRPN)
Sodium Chloride (UNII: 451W47IQ8X)
FD&C YELLOW NO. 5 (UNII: I753WB2F1M)
FD&C BLUE NO. 1 (UNII: H3R47K3TBD)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 42669-028-03	828 mL in 1 BOTTLE; Type 0: Not a Combination Product	02/15/2025

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	505G(a)(3)	02/15/2025

Labeler - Davion, Inc (174542928)